As the involvement of the lymphatic system is known to play a key role in the progression of breast cancer [17], the aim of this study was the evaluation of Interleukin 15 (IL-15) and eotaxin as markers for CTC involvement in patients with the primary diagnosis of breast cancer. This evidence concerns the gene IL15 and breast cancer.